Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Brody

Showing results (481-490 of 517) with videos related to

Pageof 52
Sort By:
Plos One|July 14, 2012
A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkersJordan M Winter, Laura H Tang, David S Klimstra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2018
Molecular Profiling of Patients with Pancreatic Cancer: Initial Results from the Know Your Tumor InitiativeMichael J Pishvaian, Robert J Bender, David Halverson, et al.
Cancer Research|June 6, 2024
IDH1 Inhibition Potentiates Chemotherapy Efficacy in Pancreatic CancerMehrdad Zarei, Omid Hajihassani, Jonathan J Hue, et al.
Molecular Cancer Research : MCR|October 23, 2014
MUC1 Promoter-Driven DTA as a Targeted Therapeutic Strategy against Pancreatic CancerRenee M Tholey, Shruti Lal, Masaya Jimbo, et al.
Cancer Biology & Therapy|July 13, 2012
HuR's post-transcriptional regulation of Death Receptor 5 in pancreatic cancer cellsDanielle M Pineda, David W Rittenhouse, Christopher C Valley, et al.
Translational Oncology|April 2, 2023
A Novel 3DNA® Nanocarrier effectively delivers payloads to pancreatic tumorsGrace A McCarthy, Aditi Jain, Roberto Di Niro, et al.
Molecular Cancer Research : MCR|March 1, 2017
CRISPR Knockout of the HuR Gene Causes a Xenograft Lethal PhenotypeShruti Lal, Edwin C Cheung, Mahsa Zarei, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
Global mRNA 3'UTR lengthening in small-cell neuroendocrine carcinomaYi Zhang, Xiaofan Zhao, Huan Wang, et al.
Cancer Research|March 8, 2013
Dormant cancer cells contribute to residual disease in a model of reversible pancreatic cancerWan-chi Lin, Nirakar Rajbhandari, Chengbao Liu, et al.
Molecular and Cellular Biology|June 15, 2022
The RNA-Binding Protein HuR Posttranscriptionally Regulates the Protumorigenic Activator YAP1 in Pancreatic Ductal AdenocarcinomaSamantha Z Brown, Grace A McCarthy, James R Carroll, et al.
Pageof 52

Showing results (481-490 of 517) with videos related to

Sort By:
Pageof 52
Plos One|July 14, 2012
A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkersJordan M Winter, Laura H Tang, David S Klimstra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2018
Molecular Profiling of Patients with Pancreatic Cancer: Initial Results from the Know Your Tumor InitiativeMichael J Pishvaian, Robert J Bender, David Halverson, et al.
Cancer Research|June 6, 2024
IDH1 Inhibition Potentiates Chemotherapy Efficacy in Pancreatic CancerMehrdad Zarei, Omid Hajihassani, Jonathan J Hue, et al.
Molecular Cancer Research : MCR|October 23, 2014
MUC1 Promoter-Driven DTA as a Targeted Therapeutic Strategy against Pancreatic CancerRenee M Tholey, Shruti Lal, Masaya Jimbo, et al.
Cancer Biology & Therapy|July 13, 2012
HuR's post-transcriptional regulation of Death Receptor 5 in pancreatic cancer cellsDanielle M Pineda, David W Rittenhouse, Christopher C Valley, et al.
Translational Oncology|April 2, 2023
A Novel 3DNA® Nanocarrier effectively delivers payloads to pancreatic tumorsGrace A McCarthy, Aditi Jain, Roberto Di Niro, et al.
Molecular Cancer Research : MCR|March 1, 2017
CRISPR Knockout of the HuR Gene Causes a Xenograft Lethal PhenotypeShruti Lal, Edwin C Cheung, Mahsa Zarei, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
Global mRNA 3'UTR lengthening in small-cell neuroendocrine carcinomaYi Zhang, Xiaofan Zhao, Huan Wang, et al.
Cancer Research|March 8, 2013
Dormant cancer cells contribute to residual disease in a model of reversible pancreatic cancerWan-chi Lin, Nirakar Rajbhandari, Chengbao Liu, et al.
Molecular and Cellular Biology|June 15, 2022
The RNA-Binding Protein HuR Posttranscriptionally Regulates the Protumorigenic Activator YAP1 in Pancreatic Ductal AdenocarcinomaSamantha Z Brown, Grace A McCarthy, James R Carroll, et al.
Pageof 52